These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

703 related items for PubMed ID: 12700914

  • 1. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
    Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O.
    J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
    [Abstract] [Full Text] [Related]

  • 2. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG, Mitchell JD, Lyon M, Moore DH.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Survival in amyotrophic lateral sclerosis].
    Alcaz S, Jarebinski M, Pekmezović T, Marinković Z, Apostolski S.
    Srp Arh Celok Lek; 1997 Sep; 125(1-2):19-23. PubMed ID: 17974351
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
    Meininger V, Asselain B, Guillet P, Leigh PN, Ludolph A, Lacomblez L, Robberecht W, Pentoxifylline European Group.
    Neurology; 2006 Jan 10; 66(1):88-92. PubMed ID: 16401852
    [Abstract] [Full Text] [Related]

  • 7. Outcome of sporadic amyotrophic lateral sclerosis treated with non-invasive ventilation and riluzole.
    Sívori M, Rodríguez GE, Pascansky D, Sáenz C, Sica RE.
    Medicina (B Aires); 2007 Jan 10; 67(4):326-30. PubMed ID: 17891927
    [Abstract] [Full Text] [Related]

  • 8. [What are the etiological medical therapies in amyotrophic lateral sclerosis?].
    Dib M.
    Rev Neurol (Paris); 2006 Jun 10; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114
    [Abstract] [Full Text] [Related]

  • 9. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
    Turner MR, Bakker M, Sham P, Shaw CE, Leigh PN, Al-Chalabi A.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar 10; 3(1):15-21. PubMed ID: 12061944
    [Abstract] [Full Text] [Related]

  • 10. Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis.
    Bruno R, Vivier N, Montay G, Le Liboux A, Powe LK, Delumeau JC, Rhodes GR.
    Clin Pharmacol Ther; 1997 Nov 10; 62(5):518-26. PubMed ID: 9390108
    [Abstract] [Full Text] [Related]

  • 11. The use of herbal supplements and alternative therapies by patients with amyotrophic lateral sclerosis (ALS).
    Vardeny O, Bromberg MB.
    J Herb Pharmacother; 2005 Nov 10; 5(3):23-31. PubMed ID: 16520295
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
    Andreadou E, Kapaki E, Kokotis P, Paraskevas GP, Katsaros N, Libitaki G, Zis V, Sfagos C, Vassilopoulos D.
    Clin Neurol Neurosurg; 2008 Mar 10; 110(3):222-6. PubMed ID: 18055102
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002).
    Zoing MC, Burke D, Pamphlett R, Kiernan MC.
    J Clin Neurosci; 2006 Jan 10; 13(1):78-83. PubMed ID: 16410201
    [Abstract] [Full Text] [Related]

  • 17. Do the benefits of currently available treatments justify early diagnosis and announcement? Arguments for.
    Cashman NR.
    Neurology; 1999 Jan 10; 53(8 Suppl 5):S50-2; discussion S55-7. PubMed ID: 10560639
    [Abstract] [Full Text] [Related]

  • 18. An association study of riluzole serum concentration and survival and disease progression in patients with ALS.
    Groeneveld GJ, van Kan HJ, Lie-A-Huen L, Guchelaar HJ, van den Berg LH.
    Clin Pharmacol Ther; 2008 May 10; 83(5):718-22. PubMed ID: 17898704
    [Abstract] [Full Text] [Related]

  • 19. Do the benefits of currently available treatments justify early diagnosis and treatment of amyotrophic lateral sclerosis? Arguments against.
    Ludolph AC, Riepe MW.
    Neurology; 1999 May 10; 53(8 Suppl 5):S46-9; discussion S55-7. PubMed ID: 10560638
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.